Finally understanding what doctors have seen for years
For generations, physicians have watched calcium etch its signature into the brains of children born with rare vascular mutations, naming the pattern but never fully understanding its origin. Researchers at the Francis Crick Institute and Great Ormond Street Hospital have now traced that origin to its source — a cellular cascade in which mutated blood vessel cells flood themselves with calcium, drawing in still more from outside in a futile attempt at balance. The discovery reframes calcium not as a bystander to suffering but as its engine, and in doing so, opens two credible paths toward intervention for children with Sturge-Weber syndrome and PPV-DM. What was once a clinical mystery visible on X-rays may, in time, become a condition medicine can meet before the damage begins.
- Children born with these rare genetic mutations face a lifetime of seizures, blindness, and progressive brain damage — conditions that appear without warning and are invisible to prenatal screening.
- A study of 42 affected children found that nearly three-quarters had abnormal calcium levels, and brain scans confirmed the deposits were not static but actively worsening over time.
- Laboratory work revealed the mechanism: mutated cells release excessive calcium internally, then overcompensate by drawing in more through CRAC channels, creating a chronic imbalance that drives neurological deterioration.
- Two interventions — a gene-silencing therapy and a CRAC channel-blocking drug — both corrected the calcium dysfunction in the lab, with the genetic approach proving the more powerful of the two.
- Researchers now believe a window exists for early intervention that could prevent calcium from ever accumulating in brain tissue, potentially sparing future children from the disabilities that have defined these diseases.
For years, doctors observed calcium deposits forming distinctive parallel lines — 'tramlines' — on the brain scans of children with rare genetic blood vessel diseases, without understanding why. A research team at the Francis Crick Institute and Great Ormond Street Hospital has now answered that question, and their answer points toward treatment.
The conditions involved — Sturge-Weber syndrome and PPV-DM — stem from mutations in the GNAQ or GNA11 genes, present in some cells but not others. Children are born with them, and the consequences are serious: seizures, developmental delays, severe headaches, blindness, and progressive brain damage, despite a normal life expectancy. The conditions appear without warning, do not run in families, and are not caught during pregnancy screening — a shock, as lead researcher Veronica Kinsler noted, that families are entirely unprepared for.
Studying 42 affected children, the team found that 74 percent had abnormal calcium measurements, and that brain deposits were worsening over time. When five patients underwent epilepsy surgery, the findings confirmed calcium was accumulating inside cells, not only in blood vessels. Laboratory work made the mechanism plain: mutated cells were releasing far too much calcium internally, then pulling in more from outside through transporters called CRAC channels in a failed attempt at compensation. This chronic imbalance, the researchers concluded, was the engine of the disease.
Both proposed solutions worked in the lab. A genetic therapy silencing the overactive gene corrected the calcium dysfunction, as did a drug blocking the CRAC channels — with the genetic approach proving more effective. The researchers believe early intervention could prevent calcium from ever accumulating in brain tissue, potentially stopping seizures before they begin. Published in the Journal of Investigative Dermatology and supported by research bodies and patient advocacy groups, the work marks a turn from observation toward the genuine possibility of prevention.
For years, doctors have watched calcium deposits accumulate in the brains of children with rare genetic blood vessel diseases, seeing them form distinctive parallel lines visible on X-rays—a pattern they called 'tramlining'—but unable to explain why. A team at the Francis Crick Institute and Great Ormond Street Hospital has now solved that puzzle, discovering that calcium imbalance is not merely a symptom of these conditions but their fundamental driver, and that this understanding opens two potential pathways to treatment.
The diseases in question—Sturge-Weber syndrome and Phakomatosis Pigmentovascularis with Dermal Melanocytosis (PPV-DM)—arise from mutations in one of two genes, GNAQ or GNA11, that appear in some cells but not others. Children are born with these conditions, which affect the skin, brain, and eyes. The symptoms are severe and progressive: seizures, developmental delays, intense headaches, blindness, and distinctive birthmarks on the face. Although people with these conditions can live a normal lifespan, many endure serious, disabling symptoms throughout their lives.
The researchers examined 42 children with either condition at Great Ormond Street Hospital and found that 74 percent had at least one abnormal calcium measurement in their blood. More tellingly, their brain calcium deposits were worsening over time. When five of these patients underwent surgery for epilepsy, the surgical findings confirmed what the team suspected: calcium was accumulating not just in the brain's blood vessels but inside the cells themselves.
In the laboratory, the picture became clear. The researchers studied patient samples and engineered blood vessel cells with and without the mutations. What they discovered was a cascade of cellular dysfunction: the mutated cells were releasing far too much calcium internally, all the time. To compensate, the cells were pulling in even more calcium from outside through specialized transporters called CRAC channels, trying to maintain balance. This chronic calcium imbalance, the team concluded, was what drove the clinical symptoms—the seizures, the brain damage, the progressive deterioration.
Testing two approaches to correct this problem, the researchers found that both worked in the laboratory. A genetic therapy designed to silence the overactive gene improved the calcium dysfunction. A drug that blocked the CRAC channels also helped. The genetic therapy proved more effective, suggesting a clear target for future treatment. The hope is that early intervention—either with genetic therapy or with drugs that address the calcium pathway—could prevent calcium deposits from accumulating in brain cells and triggering seizures in the first place.
Veronica Kinsler, who led the research, described the shock families experience when a child is born with one of these conditions. They appear without warning, do not run in families, and are not detected during pregnancy screening. For years, the calcium deposits visible on brain scans were a clinical mystery. Now, she said, the team has finally understood what doctors have been seeing in the clinic for years, and that understanding has allowed them to design potential treatments. There is, she suggested, a window of opportunity to make a difference for children facing these severe diseases.
The research was published in two papers in the Journal of Investigative Dermatology and was supported by the National Institute for Health and Care Research, the US Sturge-Weber Foundation, and patient advocacy organizations. For families living with these rare conditions, the work represents a shift from observation to intervention—the possibility that future children might be spared the progressive brain damage that has defined these diseases.
Notable Quotes
By using the power of science to work out exactly what is going on in this disease, we have finally been able to understand the calcium deposits in the brain that doctors have seen in the clinic for years.— Veronica Kinsler, Principal Group Leader at the Francis Crick Institute
The Hearth Conversation Another angle on the story
Why did doctors miss this calcium connection for so long?
The calcium deposits were visible on X-rays for years, but they looked like damage, like a consequence. Nobody realized they were the mechanism itself—that the calcium imbalance was actually driving the disease forward. It took looking inside the cells to see what was really happening.
So the cells are drowning in calcium?
In a way. The mutated cells leak calcium internally, constantly. The cell tries to fix this by pulling more calcium in from outside, which makes the problem worse. It's like a broken thermostat that keeps overheating the house.
And the genetic therapy worked better than the drug?
Yes. The drug blocks the channels that pull calcium in from outside, which helps. But the genetic therapy actually silences the gene causing the problem in the first place. It's more direct—you're stopping the leak rather than just managing the overflow.
What does 'early intervention' actually mean here?
It means treating children before the calcium deposits accumulate and cause permanent brain damage. Right now, symptoms get progressively worse over the first years of life. If you could stabilize the calcium balance early, you might prevent that cascade entirely.
Are these treatments ready for children now?
Not yet. This is laboratory work and early understanding. But it gives researchers a clear target and two strategies to pursue. That's the breakthrough—knowing what to aim for.